Inhibition of proliferation of human hela cells by small interference RNA against Pokemon gene

Chinese Journal of Cancer Research

Volumn 20, Issue 1, 2008, Pages 5-11

  Deng, Yi Jing ^a   Ni, Bing ^a   Jiang, Man ^a   Yang, Di ^a   Li, Fan ^a   Wu, Yu Zhang ^a  

^a CHINESE PLA GENERAL HOSPITAL   (China)

Author keywords

Colony forming assay; Pokemon; Retrovirus, siRNA

Indexed keywords

SMALL INTERFERING RNA; TRANSCRIPTION FACTOR; TRANSCRIPTIONAL FACTOR POKEMON; TRANSFER RNA; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CANCER CELL CULTURE; CELL PROLIFERATION; COLONY FORMING CELL; CONTROLLED STUDY; GENE SILENCING; GENE TARGETING; HELA CELL; HUMAN; HUMAN CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; RECOMBINANT PLASMID; RETROVIRUS; UTERINE CERVIX CANCER; VIRUS RECOMBINANT;

EID: 41149163817     PISSN: 10009604     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11670-008-0005-4     Document Type: Article

References (31)

1. Kim YT, Zhao M. Aberrant cell cycle regulation in cervical carcinoma [J]. Yonsei Med J 2005; 31;46:597-613.
2. Melnick A, Ahmad KF, Arai S, et al. In-depth mutational analysis of the promyelocytic leukemia zinc finger BTB/POZ domain reveals motifs and residues required for biological and transcriptional functions [J]. Mol Cell Biol 2000; 20:6550-67.
3. Lin, RJ, Nagy L, Inoue S, et al. Role of the histone deacetylase complex in acute promyelocytic leukaemia [J]. Nature 1998; 391:811-4.
4. Melnick A, Carlile G, Ahmad KF, et al. Critical residues within the BTB domain of PLZF and Bcl-6 modulate interaction with corepressors [J]. Mol Cell Biol 2002; 22:1804-18.
5. Barna M, Hawe N, Niswander L, et al. Plzf regulates limb and axial skeletal patterning [J]. Nat Genet 2000; 25:166-72.
6. Ye BH, Cattoretti G, Shen Q, et al. The BCL-6 proto-oncogene controls germinal-centre formation and Th2-type inflammation [J]. Nat Genet 1997; 16: 161-70.
7. Adhikary S, Peukert K, Karsunky H, et al. Miz1 is required for early embryonic development during gastrulation [J]. Mol Cell Biol 2003; 23:7648-57.
8. Carter MG, Johns MA, Zeng X, et al. Mice deficient in the candidate tumor suppressor gene Hic1 exhibit developmental defects of structures affected in the Miller-Dieker syndrome [J]. Hum Mol Genet 2000; 9:413-9.
9. Chen WY, Zeng X, Carter MG, et al. Heterozygous disruption of Hic1 predisposes mice to a gender-dependent spectrum of malignant tumors [J]. Nat Genet 2003; 33: 197-202.
10. Lee DK, Suh D, Edenberg HJ, et al. POZ domain transcription factor, FBI-1, represses transcription of ADH5/FDH by interacting with the zinc finger and interfering with DNA binding activity of Sp1 [J]. J Biol Chem 2002; 277:26761-8.
11. Pessler F, Hernandez N. Flexible DNA binding of the BTB/POZ-domain protein FBI-1 [J]. J Biol Chem 2003; 278:29327-35.
12. Liu CJ, Prazak L, Fajardo M. Leukemia/lymphoma-related factor, a POZ domain-containing transcriptional repressor, interacts with histone deacetylase-1 and inhibits cartilage oligomeric matrix protein gene expression and chondrogenesis [J]. J Biol Chem 2004; 279:47081-91.
13. Maeda T, Hobbs RM, Merghoub T, et al. Role of the proto-oncogene Pokemon in cellular transformation and ARF repression [J]. Nature 2005; 433:278-85.
14. Shankar P, Manjunath N, Lieberman J. The prospect of silencing disease using RNA interference [J]. JAMA 2005; 293:1367-73.
15. Hannon GJ. RNA interference [J]. Nature 2002; 418:244-51.
16. Bernstein E, Denli AM, Hannon GJ. The rest is silence [J]. RNA 2001; 7:1509-21.
17. Elbashir SM, Harborth J, Lendeckel W, et al. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cell [J]. Nature 2001; 411:494-8.
18. Shankar P, Manjunath N, Lieberman J. The prospect of silencing disease using RNA interference [J]. JAMA 2005; 293:1367-73.
19. Bantounas I, Phylactou LA, Uney JB. RNA interference and the use of small interfering RNA to study gene function in mammalian systems [J]. J Mol Endocrinol 2004; 33:545-57.
20. Marcellus RC, Lavoie JN, Biovin D, et al. The early region 4 orf4 protein of human adenovirus type 5 induces p53-independent cell death by apoptosis. J Virol 1998; 72:7144-53.
21. Coren JS, Sternberg N. Construction of a PAC vector system for the propagation of genomic DNA in bacterial and mammalian cells and subsequent generation of nested deletions in individual library members [J]. Gene 2001; 264:11-8.
22. Morrison DJ, Pendergrast PS, Stavropoulos P, et al. FBI-1, a factor that binds to the HIV-1 inducer of short transcripts (1ST), is a POZ domain protein. [J]. Nucleic Acids Res 1999; 27:1251-62.
23. Walsh CT, Zydowsky LD, McKeon FD. Cyclosporin A, the cyclophilin class of peptidylprolyl isomerases, and blockade of T cell signal transduction [J]. J Biol Chem 1992; 267:13115-8.
24. Elbashir SM, Martinez J, Patkaniowska A, et al. Functional anatomy of siRNAs for mediating efficient RNAi in Drosophila melanogaster embryo lysate [J]. EMBO J 2001; 20:6877-88.
25. Davies, JM, Hawe N, Kabarowski J, et al. Novel BTB/POZ domain zinc-finger protein, LRF, is a potential target of the LAZ-3/BCL-6 oncogene [J]. Oncogene 1999; 18:365-75.
26. Albagli O, Dhordain P, Deweindt C, et al. The BTB/POZ domain: a new protein-protein interaction motif common to DNA- and actin-binding proteins [J]. Cell Growth Differ 1995; 6:1193-8.
27. Bardwell VJ, Treisman R. The POZ domain: a conserved protein-protein interaction motif [J]. Genes Dev 1994; 8:1664-77.
28. Dhordain P, Lin RJ, Quief S, et al. The LAZ3 (BCL-6) oncoprotein recruits a SMRT/mSIN3A/histone deacetylase containing complex to mediate transcriptional repression [J]. Nucleic Acids Res 1998; 26:4645-51.
29. Lo Coco, F, Ye BH, Lista F, et al. Rearrangements of the BCL6 gene in diffuse large cell non-Hodgkin's lymphoma [J]. Blood 1994; 83:1757-9.
30. David, G, Alland L, Hong SH, et al. Histone deacetylase associated with mSin3A mediates repression by the acute promyelocytic leukemia-associated PLZF protein [J]. Oncogene 1998; 16:2549-56.
31. Dong S, Zhu J, Reid A, et al. Amino-terminal protein-protein interaction motif (POZ-domain) is responsible for activities of the promyelocytic leukemia zinc finger-retinoic acid receptor-alpha fusion protein [J]. Proc Natl Acad Sci USA 1996; 93:3624-9.